Your browser doesn't support javascript.
loading
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Ellingson, Benjamin M; Abrey, Lauren E; Garcia, Josep; Chinot, Olivier; Wick, Wolfgang; Saran, Frank; Nishikawa, Ryo; Henriksson, Roger; Mason, Warren P; Harris, Robert J; Leu, Kevin; Woodworth, Davis C; Mehta, Arnav; Raymond, Catalina; Chakhoyan, Ararat; Pope, Whitney B; Cloughesy, Timothy F.
Afiliação
  • Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Abrey LE; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Garcia J; Department of Physics and Biology in Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Chinot O; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, California, USA.
  • Wick W; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Saran F; UCLA Brain Research Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Nishikawa R; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Henriksson R; F. Hoffman-La Roche, Ltd.
  • Mason WP; F. Hoffman-La Roche, Ltd.
  • Harris RJ; Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France.
  • Leu K; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
  • Woodworth DC; The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Mehta A; Saitama Medical University, Saitama, Japan.
  • Raymond C; Regional Cancer Center Stockholm, Stockholm, Sweden and Umeå University, Umeå, Sweden.
  • Chakhoyan A; Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Pope WB; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Cloughesy TF; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Neuro Oncol ; 20(11): 1525-1535, 2018 10 09.
Article em En | MEDLINE | ID: mdl-29897562

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Carga Tumoral / Quimiorradioterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Glioblastoma / Carga Tumoral / Quimiorradioterapia Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido